The Problem With Jane Goodall’s “Expert” Opinion

On September 7, 2017, Dr. Jane Goodall wrote a scathing letter to Dr. Scott Gottlieb, Commissioner of the U.S. Food & Drug Administration (FDA) denouncing what she called the “cruel and unnecessary nicotine addiction experiments on monkeys” occurring there. The letter, which relies on the repeated use of opinion versus fact-based arguments by Goodall, is … Continue reading The Problem With Jane Goodall’s “Expert” Opinion

FDA response to Goodall letter found lacking

On September 25, 2017, Dr. Scott Gottlieb , Commissioner of the U.S. Food & Drug Administration (FDA) replied to a scathing letter from Dr. Jane Goodall, where Goodall denounced what she called the “cruel and unnecessary nicotine addiction experiments on monkeys”. We previously evaluated that letter from Goodall and now do the same with Commissioner Gottlieb’s letter. … Continue reading FDA response to Goodall letter found lacking

Jane Goodall and White Coat Waste are wrong about nicotine addiction research

This open letter is from scientists and leaders in the addiction research community.  If you’d like to join the signatories listed below, please do in comments at the bottom of this article. Please also share with others with an interest in research on addiction. Smoking – and nicotine addiction – are sometimes easy targets for … Continue reading Jane Goodall and White Coat Waste are wrong about nicotine addiction research

A fresh approach to animal rights activism…or is it?

White Coat Waste says it’s using unique new strategies to campaign against animal studies…our analysis suggests otherwise. Over the past few months, several news stories have focused on a relatively new animal rights organization, one that we have mentioned in previous posts. The group, called the White Coat Waste Project, has been portrayed as a … Continue reading A fresh approach to animal rights activism…or is it?

Research Roundup: Considering the bleak future of animal research without primates, heroin vaccine brought one step closer to availability and more!

Welcome to this week’s Research Roundup. These Friday posts aim to inform our readers about the many stories that relate to animal research each week. Do you have an animal research story we should include in next week’s Research Roundup? You can send it to us via our Facebook page or through the contact form … Continue reading Research Roundup: Considering the bleak future of animal research without primates, heroin vaccine brought one step closer to availability and more!

FDA announcement regarding termination of primate study leaves many questions unanswered

On Friday, January 26, the US Food and Drug Administration (FDA)—the agency charged with protecting public health via oversight of food, drugs, and medical devices—issued a statement about its decision to terminate a nicotine research project at the National Center for Toxicology Research (NCTR). The research had been the focus of campaign by an anti-animal … Continue reading FDA announcement regarding termination of primate study leaves many questions unanswered

Response to FDA statement on termination of a primate nicotine research study

The US Food and Drug Administration (FDA)  announced yesterday that it terminated a study investigating the effects of nicotine in monkeys.  This announcement, which was accompanied by the release of many records and documents related to the animals’ care, is troubling for many reasons.  Among them, it again raises questions about oversight and decision-making. Nicotine … Continue reading Response to FDA statement on termination of a primate nicotine research study

Is the FDA undermining its own study and the experts it sent to review it?

The American Psychological Association has warned that the FDA may be winding down its own primate study, despite having started– but not completed, nor made public– an independent FDA review process. Why the FDA would stop the study before any report has been published will lead many into further questioning the influence that certain animal … Continue reading Is the FDA undermining its own study and the experts it sent to review it?